Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes. — R'EHPAD

Drug Resistance, Bacterial Clinical Trial

Official title:
Determination of the Prevalence of ESBL-producing Enterobacteriaceae as Carbapenem-resistant Enterobacteriaceae in Nursing Homes in Franche-Comté (France).

Status Completed

Clinical Trial Summary

This study evaluates individual and collective factors of ESBL and CRE carriage in nursing homes.

Clinical Trial Description

Epimiological data concerning ESBL an CRE, may differ between nursing home and hospital or community but poor data are available.

Multi-drug resistant bacteria carriage is associated with individual and collective factors wich have to be defined in nursing homes. ;

Study Design

Related Conditions & MeSH terms

Drug Resistance, Bacterial

Clinical Trial Details

NCT number	NCT03248999
Study type	Interventional
Source	Centre Hospitalier Universitaire de Besancon
Contact
Status	Completed
Phase	N/A
Start date	November 20, 2017
Completion date	June 26, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06156956` - Fecal Microbiota Transplantation (FMT) to Decolonize Antibiotic - Resistant Bacteria (ARB) - New Protocol	N/A
Enrolling by invitation	`NCT05378880` - Optimising Community Antibiotic Use and Infection Control With Behavioural Interventions in Burkina Faso and DR Congo	N/A
Completed	`NCT00484055` - Local Collagen-Gentamicin and Extra Fixation of the Sternum for Prevention of Sternal Wound Infection in Cardiac Surgery	N/A
Recruiting	`NCT03891433` - Piperacillin/Tazobactam Versus Carbapenems in Non-bacteremic UTI Due to -ESBL-producing Enterobacteriaceae	Phase 4